255 related articles for article (PubMed ID: 19254747)
1. Differential regulation of urocortins1-3 mRNA in human umbilical vein endothelial cells.
Kageyama K; Hanada K; Suda T
Regul Pept; 2009 Jun; 155(1-3):131-8. PubMed ID: 19254747
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation and roles of urocortins in human adrenal H295R cells.
Kageyama K; Hanada K; Suda T
Regul Pept; 2010 Jun; 162(1-3):18-25. PubMed ID: 20171993
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of glucocorticoids on urocortin-mediated increases in interleukin-6 gene expression in rat aortic smooth muscle cells.
Kageyama K; Hanada K; Nigawara T; Furukawa K; Terui K; Ogura E; Motomura S; Suda T
Peptides; 2007 May; 28(5):1059-67. PubMed ID: 17346851
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of gonadotropin-releasing hormone by corticotropin-releasing factor family peptides in hypothalamic N39 cells.
Kageyama K; Hasegawa G; Akimoto K; Yamagata S; Tamasawa N; Suda T
Peptides; 2012 Jan; 33(1):149-55. PubMed ID: 22138165
[TBL] [Abstract][Full Text] [Related]
6. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
[TBL] [Abstract][Full Text] [Related]
7. Mapping the CRF-urocortins system in human osteoarthritic and rheumatoid synovial fibroblasts: effect of vasoactive intestinal peptide.
Pérez-García S; Juarranz Y; Carrión M; Gutiérrez-Cañas I; Margioris A; Pablos JL; Tsatsanis C; Gomariz RP
J Cell Physiol; 2011 Dec; 226(12):3261-9. PubMed ID: 21360527
[TBL] [Abstract][Full Text] [Related]
8. Regulation and roles of urocortins in the vascular system.
Kageyama K; Teui K; Tamasawa N; Suda T
Int J Endocrinol; 2012; 2012():873723. PubMed ID: 22654906
[TBL] [Abstract][Full Text] [Related]
9. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
10. Modulation of corticotropin-releasing hormone type 2 receptor and urocortin 1 and urocortin 2 mRNA expression in the cardiovascular system of prairie voles following acute or chronic stress.
Pournajafi-Nazarloo H; Partoo L; Sanzenbacher L; Azizi F; Carter CS
Neuroendocrinology; 2007; 86(1):17-25. PubMed ID: 17551267
[TBL] [Abstract][Full Text] [Related]
11. Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders.
Fukuda T; Takahashi K; Suzuki T; Saruta M; Watanabe M; Nakata T; Sasano H
J Clin Endocrinol Metab; 2005 Aug; 90(8):4671-8. PubMed ID: 15914529
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the expression and secretion of urocortin 2 in rat pituitary.
Nemoto T; Iwasaki-Sekino A; Yamauchi N; Shibasaki T
J Endocrinol; 2007 Feb; 192(2):443-52. PubMed ID: 17283244
[TBL] [Abstract][Full Text] [Related]
13. Regulation of urocortin I and its related peptide urocortin II by inflammatory and oxidative stresses in HL-1 cardiomyocytes.
Ikeda K; Tojo K; Inada Y; Takada Y; Sakamoto M; Lam M; Claycomb WC; Tajima N
J Mol Endocrinol; 2009 Jun; 42(6):479-89. PubMed ID: 19318426
[TBL] [Abstract][Full Text] [Related]
14. Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes.
Imperatore A; Florio P; Torres PB; Torricelli M; Galleri L; Toti P; Occhini R; Picciolini E; Vale W; Petraglia F
Am J Obstet Gynecol; 2006 Jul; 195(1):288-95. PubMed ID: 16626608
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
[TBL] [Abstract][Full Text] [Related]
16. Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors.
Takahashi K; Totsune K; Saruta M; Fukuda T; Suzuki T; Hirose T; Imai Y; Sasano H; Murakami O
Peptides; 2006 Jan; 27(1):178-82. PubMed ID: 16095756
[TBL] [Abstract][Full Text] [Related]
17. Changes in placental CRH, urocortins, and CRH-receptor mRNA expression associated with preterm delivery and chorioamnionitis.
Torricelli M; Novembri R; Bloise E; De Bonis M; Challis JR; Petraglia F
J Clin Endocrinol Metab; 2011 Feb; 96(2):534-40. PubMed ID: 21106714
[TBL] [Abstract][Full Text] [Related]
18. Localized expression of urocortin genes in the developing zebrafish brain.
Bräutigam L; Hillmer JM; Söll I; Hauptmann G
J Comp Neurol; 2010 Aug; 518(15):2978-95. PubMed ID: 20533356
[TBL] [Abstract][Full Text] [Related]
19. Effects of urocortin 2 and urocortin 3 on IL-10 and TNF-α expression and secretion from human trophoblast explants.
Novembri R; Torricelli M; Bloise E; Conti N; Galeazzi LR; Severi FM; Petraglia F
Placenta; 2011 Dec; 32(12):969-74. PubMed ID: 22000474
[TBL] [Abstract][Full Text] [Related]
20. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
